<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02940106</url>
  </required_header>
  <id_info>
    <org_study_id>2016/245</org_study_id>
    <nct_id>NCT02940106</nct_id>
  </id_info>
  <brief_title>Clinical Pregnancies After Cryopreservation of Donor Oocytes With an Open or Closed Device</brief_title>
  <official_title>Investigation of the Clinical Pregnancies Obtained After Cryopreservation of Donor Oocytes With an Open or Closed Device</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitair Ziekenhuis Brussel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitair Ziekenhuis Brussel</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomized pilot study will assess if there is a difference in clinical pregnancies
      using donor oocytes cryopreserved in either a closed or a semi-closed vitrification device.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Oocyte cryopreservation was optimized by the use of a new technique: vitrification.
      Vitrification can be performed using either open devices (where the oocytes are in direct
      contact with the liquid nitrogen) or closed systems (where the oocytes are never in contact
      with liquid nitrogen). Previous studies have associated the use of open devices to higher
      oocyte survival rates and better embryo development. However, any beneficial effect on
      clinical pregnancy rates is yet to be proven. Hence, the objective of this study is to
      compare the clinical pregnancy rates of open and closed oocyte vitrification devices.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2016</start_date>
  <completion_date type="Anticipated">July 2018</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical pregnancy</measure>
    <time_frame>7 weeks</time_frame>
    <description>Pregnancy determined by ultrasound</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>survival</measure>
    <time_frame>1 week</time_frame>
    <description>oocyte survival post-warming based on the morphological appearance of the oocytes immediately after warming: degenerated oocytes are non-surviving oocytes; oocytes with a normal morphological appearance are surviving oocytes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>fertilization</measure>
    <time_frame>1 week</time_frame>
    <description>oocyte fertilization post-insemination: the day after oocyte insemination fertilization is checked: if one male and one female pronucleus appear, the oocyte is fertilized. if both nuclei are not present or more nuclei are present, the oocyte is considered not fertilized.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>embryo development</measure>
    <time_frame>2 weeks</time_frame>
    <description>embryo development post-fertilization: on day 3 of pre-implantation development, the embryo is scored for the number of cells, fragmentation, appearance of nuclei and other embryological parameters: based on these parameters, an embryological score is given to the embryo. On day 5 of development (blastocyst stage) another score is given to the embryo based on the appearance of the trophectoderm and inner cell mass cells.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>closed device</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Standard cryopreservation system.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>open device</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>New cryopreservation system.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cryotop device</intervention_name>
    <description>a different device for oocyte vitrification (with a very high cooling rate)</description>
    <arm_group_label>open device</arm_group_label>
    <other_name>Cryotop open vitrification device (Kitazato)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CBSvit device</intervention_name>
    <description>a different device for oocyte vitrification (with a lower cooling rate)</description>
    <arm_group_label>closed device</arm_group_label>
    <other_name>CBSvit closed vitrification device (CryoBioSystems vitrification device)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  this is a pragmatic randomized clinical trial. Hence, all consenting oocyte recipients
             will be eligible for the study

        Exclusion Criteria:

          -  women who do not consent or that cannot comprehend the investigational nature of the
             study
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>47 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Neelke De Munck, MSc.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitair Ziekenhuis Brussel</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Neelke De Munck, MSc.</last_name>
    <phone>00324776694</phone>
    <email>neelke.demunck@uzbrussel.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Greta Verheyen, PhD</last_name>
    <phone>024776672</phone>
    <email>greta.verheyen@uzbrussel.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Universitair Ziekenhuis Brussel</name>
      <address>
        <city>Brussels</city>
        <zip>1090</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Neelke De Munck, MSc.</last_name>
      <phone>024776694</phone>
      <phone_ext>0032</phone_ext>
      <email>neelke.demunck@uzbrussel.be</email>
    </contact>
    <investigator>
      <last_name>Neelke De Munck, MSc.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <reference>
    <citation>De Munck N, Santos-Ribeiro S, Stoop D, Van de Velde H, Verheyen G. Open versus closed oocyte vitrification in an oocyte donation programme: a prospective randomized sibling oocyte study. Hum Reprod. 2016 Feb;31(2):377-84. doi: 10.1093/humrep/dev321. Epub 2016 Jan 2.</citation>
    <PMID>26724798</PMID>
  </reference>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 11, 2016</study_first_submitted>
  <study_first_submitted_qc>October 18, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 20, 2016</study_first_posted>
  <last_update_submitted>October 23, 2017</last_update_submitted>
  <last_update_submitted_qc>October 23, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 24, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitair Ziekenhuis Brussel</investigator_affiliation>
    <investigator_full_name>Neelke De Munck</investigator_full_name>
    <investigator_title>Master in Science</investigator_title>
  </responsible_party>
  <keyword>oocyte cryopreservation</keyword>
  <keyword>closed vitrification</keyword>
  <keyword>open vitrification</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

